Nature’s way to keep tissues healthy Category Cosmetics,  Cosmoceuticals, Aging Skin Development Stage Completed in vitro experiments, ready to develop a dossier documenting safety, efficacy in humans and manufacturing details (EEC-6th/7th ...

Category LifeSciences and BioTechnology    Keywords colorectal cancer, gut microbiota, personalized medicine Current development stage               For Pharmaceutical development: TRL4 - POC & Safety of candidate drug formulation is ...

Category Agriculture Keywords Anti Biofilm, Biological Control, Controlled Release, Environmentally Friendly Current development stage General list: TRL2  Technology Concept Formulated          Collaboration Opportunity Sponsored Research ...

  Category LifeSciences and BioTechnology    Keywords Parkinson’s Disease, PD, Dementia, Diagnostic Kit, Diagnostics, Non-Motor Symptoms, mRNA, Circulating RNA Current development stage General list: TRL3 Experimental proof of ...

  Category LifeSciences and BioTechnology    Keywords epilepsy, rare disease, gene therapy Current development stage For pharmaceutical development: TRL4 - POC & Safety of candidate drug formulation is demonstrated in defined animal ...

  Category Food & Environment Keywords Molecular genetic chip, smuggling, wildlife, veterinary forensics Current development stage General list: TRL2  Technology Concept Formulated         Collaboration Opportunity Sponsored Research ...

  Category Life Sciences and Biotechnology    Keywords Ultra low dose radiation CT scanning, repeat CT scanning Current development stage For medical device: TRL3 - Hypothesis testing and initial POC is demonstrated in limited number of ...

  Category Life Sciences and Biotechnology    Keywords Metabolic Syndrome, Transfer RNA fragments, Fatty liver disease, Diagnostics, Antisense oligonucleotide therapeutics, Biomarkers, Hepatic hyperlipidemia Current development stage For ...

Protein Secretion is a fundamental aspect in production of therapeutic proteins in eukaryotic cells. Most therapeutic proteins are produced as secreted proteins in mammalian cells such as CHO and HEK293.  An essential milestone in the production ...

Nir-Paz Ran, Hadassah Medical Center Background The World Health Organization has announced antibiotic resistance is one of the biggest threats to global health, food security and development today. Up to 50% of infections in G7 countries may be ...

Background Degenerative diseases become prominent with progressive ageing and thus present the most urgent biomedical challenge facing developed countries to date. One of the most prevalent musculoskeletal diseases caused during aging ...

  Category LifeSciences and BioTechnology    Keywords Pain, Opioid receptor, Addiction, Opioid addiction, Narcotics, AnalgesiaApplication Severe, high-impact chronic pain affects 20 million people in the US annually, and presents a common, ...

  Background Current methods of tissue fixation leave much to be desired, essentially relying on technologies developed from the clothing and carpentry industries i.e. sutures, screws, and pins. Bioadhesives offer a less traumatic method of ...

  Background Neutrophils are potent effector cells in a wide number of infectious, inflammatory and cancerous conditions. Modulation of Neutrophil functions in these conditions may have significant therapeutic benefits and effects on disease ...

Background To date, clinical tests that assess the level of malignancies from patient biopsies rely almost inclusively on histological analysis for specific markers and morphological cues as well as on genetic data i.e mutation analysis. In ...

  Cancer research is moving into the frontiers of how to assign the correct drug(s) to a given patient. Cancer clinicians and researchers commonly search for overexpression of oncogenic biomarkers to assign a targeted treatment, but lack ...

Background   Considerable efforts have been invested in recent years in developing new, effective, yet less toxic drugs for targeted cancer therapy. Currently, this diverse group of drugs includes monoclonal antibodies, immunomodulators, ...

Background The physical size of protein drugs and their susceptibility to degradation are key determinates that make them more dependent on drug delivery technologies. However formulating protein delivery systems so that they maintain their ...